How vaccines that target specific forms of cancer are showing great promise
A new treatment for two of the most deadly and hard-to-treat cancers could be coming in the form of a vaccine.
Showing 10 of 87 results
A new treatment for two of the most deadly and hard-to-treat cancers could be coming in the form of a vaccine.
Kids are using pricey skincare products meant to ward off aging and fine lines. But Northeastern experts say this may be futile.
The days are finally getting longer, but the sun is still low in the sky — and that means you probably aren’t getting your recommended daily allowance of vitamin D through solar rays alone.
Junhyuk “Jay” Choi had a dream of opening his own pharmacy. That is why he enrolled into Northeastern University’s doctor of pharmacy program.
Bouvé scientist Stephen Hatfield has developed an 'off-the-shelf' treatment for tumor cancers.
Ken and Christina Procaccianti met on the Green Line while attending Northeastern. Years later — inspired by the entrepreneurial spirit on campus — they launched Green Line Apothecary, now serving all of Rhode Island.
Alzheimer’s and related forms of dementia are commonplace with the Centers for Disease Control and Prevention reporting that 5.8 million people in the United States live with these diseases. This number is expected to rise to 14 million by 2060.
The COVID-19 winter forecast is for relatively mild illness thanks to vaccination and natural immunity, health experts at Northeastern University say.
Have you ever been exposed to someone with COVID-19, or had the sniffles, and reached for an at-home test in your medicine cabinet—only to notice it’s way past the expiration date stamped on the box?
Bouvé experts say vaccines differ according to whether the viruses they’ve been designed to quell are mutating or stable.